Zusammenfassung
Die chronische Analfissur ist ein häufiges proktologisches Leiden. Für die chemische temporäre Denervierung kann Botulinumtoxin (BTX) eingesetzt werden. Die Applikation erfolgt mittels intramuskulärer Injektion in den äußeren oder inneren Sphincter ani. Wirkungsweise, Applikationstechnik, mögliche Komplikationen und Nebenwirkungen werden besprochen. Die Heilungsraten sind dosisabhängig und liegen kurzfristig (≤ 6 Monate) zwischen 60 und 90 %. Die Heilungsraten bei Nachbeobachtung > 1 Jahr erreichen ca. 50 %. Die Nebenwirkungen sind gering, Rezidive aber häufiger als bei chirurgischer Behandlung. Dennoch wird heute die Anwendung der konservativen Verfahren einschließlich BTX überwiegend in der First-Line-Therapie der chronischen Analfissur verwendet. Unter den chirurgischen Verfahren bleibt die laterale Sphinkterotomie der Goldstandard, der allerdings mit einer höheren Inkontinenz- und allgemeinen Morbiditätsrate einhergeht als dies für BTX der Fall ist.
Abstract
Chronic anal fissure is a common proctological disease. Botulinum toxin (BTX) can be used for temporary chemical denervation. The administration is by intramuscular injections into either the external or the internal anal sphincter muscles. The mode of action, administration techniques and possible complications or adverse effects of BTX therapy are discussed. The healing rate is dependent on the BTX dosage. The short-term healing rate (≤ 6 months) is between 60 and 90 %. In long-term follow-up studies (> 1 year), about 50 % of patients show a complete response. Adverse effects are generally mild but relapses occur more often compared to surgery. Conservative therapies including BTX are currently considered mostly as the first-line treatment. Among the surgical procedures, lateral sphincterotomy is the most effective treatment but shows higher incontinence and general morbidity rates than BTX.
Schlüsselwörter
Analfissur - Botulinumtoxin - laterale Sphinkterotomie - Therapiealgorithmus
Key words
anal fissure - botulinum toxin - lateral sphincterotomy - therapeutic algorithm
Literatur
1
Acheson A G, Scholefield J H.
Pharmacological advancements in the treatment of chronic anal fissure.
Expert Opin Pharmacother.
2005;
6
2475-2481
2
Arroyo A, Pérez F, Serrano P, Candela F, Calpena R.
Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study.
Int J Colorectal Dis.
2005;
20
267-271
3
Arroyo A, Pérez F, Serrano P, Candela F, Lacueva J, Calpena R.
Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.
Am J Surg.
2005;
189
429-434
4
Bechara F G, Sand M, Sand D, Achenbach R K, Altmeyer P, Hoffmann K.
Focal hyperhidrosis of the anal fold: a simple technique for diagnosis and evaluation of therapy.
Br J Dermatol.
2006;
155
858
5
Bhardwaj R, Vaizey C J, Boulos P B, Hoyle C H.
Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures.
Gut.
2000;
46
861-868
6
Brin M E.
Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.
Muscle Nerve.
1997;
20 (Suppl 6)
S 146-S 168
7
Brisinda G, Maria G, Bentivoglio A R, Cassetta E, Gui D, Albanese A.
A comparison of injections of botulinum toxin and topical nitroglycerine ointment for the treatment of chronic anal fissure.
N Engl J Med.
1999;
341
65-69
8
Brisinda G, Maria G, Sganga G, Bentivoglio A R, Albanese A, Castagneto M.
Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures.
Surgery.
2002;
131
179-184
9
Colak T, Ipek T, Kanik A, Aydin S.
A randomized trial of botulinum toxin vs. lidocain pomade for chronic anal fissure.
Acta Gastro-Enterol Belg.
2002;
65
187-190
10
De Nardi P, Ortolano E, Radaelli G, Stadacher C.
Comparison of glycerine trinitrate and botulinum toxin-A for the treatment of chronic anal fissures: long-term results.
Dis Colon Rectum.
2006;
49
427-432
11
Essani R, Sarkisyan G, Beart R W, Ault G, Vukasin P, Kaiser A M.
Cost-saving effect of treatment algorithm for chronic anal fissure: a prospective analysis.
J Gastrointest Surg.
2005;
9
1237-1244
12
Fernandez-Lopez F, Conde Freire R, Rios Rios A, Carcia Iglesias J, Cainzos Fernandez M, Potel Lesquereux J.
Botulinum toxin for the treatment of anal fissure.
Dig Surg.
1999;
16
515-518
13
Floyd N D, Kondylis L, Kondylis P D, Reilly J C.
Chronic anal fissure: 1994 and a decade later - are we doing better?.
Am J Surg.
2006;
191
344-348
14
Giral A, Memisoglu K, Gültekin Y, Imeryüz N, Kalayc C, Ulusoy N B, Tözün N.
Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.
BMC Gastroenterol.
2004;
4
7
15
Godevenos D, Pikoulis E, Pavlakis E, Daskalakis P, Stathoulopoulos A, Gavrielatou E, Leppäniemi A.
The treatment of chronic anal fissure with botulinum toxin.
Acta Chir Belg.
2004;
104
577-580
16
Gui D, Cassetta E, Anastasio G, Bentivoglo A R, Maria G, Albanese A.
Botulinum toxin for chronic anal fissure.
Lancet.
1994;
344
1127-1128
17
Horsch D, Kirsch J J, Weihe E.
Elevated density and plasticity of nerve fibres in anal fissures.
Int J Colorectal Dis.
1998;
13
134-140
18
Huang W, Foster J A, Rogachefsky A S.
Pharmacology of botulinum toxin.
J Am Acad Dermatol.
2000;
43
249-259
19
Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P.
Randomized prospective controlled trial of lateral internal sphincterotomy versus injections of botulinum toxin for the treatment of idiopathic fissure in ano.
ANZ J Surg.
2005;
75
553-555
20
Jones O M, Brading A F, McC Mortensen N J.
The physiology, pharmacology and therapeutic manipulation of the internal anal sphincter.
Can J Gastroenterol.
2002;
16
249-257
21
Jost W H.
One hundred cases of anal fissure treated with botulinum toxin: early and long-term results.
Dis Colon Rectum.
1997;
40
1029-1032
22
Jost W H, Schannes S, Mlitz H, Schimrigk K.
Perianal thrombosis following injection therapy into the external sphincter using botulinum toxin.
Dis Colon Rectum.
1995;
38
781
23
Jost W H, Schimrigk K.
Use of botulinum toxin in anal fissure.
Dis Colon Rectum.
1993;
36
974
24
Jost W H, Schimrigk K.
Therapy of anal fissure using botulinum toxin.
Dis Colon Rectum.
1994;
37
1340
25
Kinney T P, Shah A G, Rogers B HG, Ehrenpreis E D.
Retrograde endoscopic delivery of botulinum toxin for anal fissures.
Endoscopy.
2006;
38
654
26
Lindsey I, Jones O M, Cinningham C, George B D, Mostensen N JM.
Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate.
Dis Colon Rectum.
2003;
46
361-366
27
Lysy J, Israelit-Ytzkan Y, Sestiery-Ittah M, Weksler-Zangen S, Keret D, Goldin E.
Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure.
Gut.
2001;
48
221-224
28
Madalinski M H, Slawek J, Zbytek B, Duzynski W, Adrich Z, Jagiello K, Kryszewski A.
Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure.
Hepato-Gastroenterol.
2001;
48
977-979
29
Maria G, Casetta E, Gui D, Brisinda G, Bentivoglio A R, Albanese A.
A comparison of botulin toxin and salin for the treatment of chronic anal fissure.
N Engl J Med.
1998;
338
217-220
30
Maria G, Brisinda G, Bentivoglio A R, Cassetta E, Gui D, Albanese A.
Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens.
Ann Surg.
1998;
228
664-669
31
Maria G, Brisidina G, Bentivoglio A R, Cassetta E, Gui D, Albanese A.
Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure.
Am J Surg.
2000;
179
46-50
32
Massoud B -W, Mehrdad V, Baharak T, Alireza Z.
A comparison of botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure.
Ann Saudi Med.
2005;
25
140-142
33
McCallion K, Gardiner K R.
Progress in the understanding and treatment of chronic anal fissure.
Postgrad Med J.
2001;
77
753-758
34
Mentes B B, Írkörücü, Akin M, Leventoglu S, Tatlicioglu E.
Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
Dis Colon Rectum.
2003;
46
232-237
35
Minguez M, Melo F, Espi A, Garcia-Granero E, Mora F, Lledo S, Benages A.
Therapeutic effects of different doses of botulinum toxin in chronic anal fissure.
Dis Colon Rectum.
1999;
42
1016-1021
36
Nelson R.
Operative procedures for fissure in ano (Cochrane Review).
Cochrane Database Syst Rev.
2001;
3
CD002199
37
Nelson R.
A systematic review of medical therapy for anal fissure.
Dis Colon Rectum.
2004;
47
422-431
38
Orsay C, Rakinic J, Perry W B, Hyman N, Buie D, Cataldo P, Newstead G, Dunn G, Rafferty J, Ellis N, Shellito P, Gregorcyk S, Ternent C, Kilkenny III J, Tjandra J, Ko C, Whiteford M, Nelson R.
Practise parameters for the management of anal fissures (revised) prepared by The Standard Practise Task Force, The American Society of Colon and Rectal Surgeons.
Dis Colon Rectum.
2004;
47
2003-2007
39
Rosales R L, Bigalke H, Dressler D.
Pharmacology of botulinum toxin: differences between type A preparations.
Eur J Neurol.
2006;
13 (Suppl 1)
2-10
40
Singer M, Citron J.
New techniques in the treatment of common perianal diseases: stapled hemorrhoidopexy, botulinum toxin, and fibrin sealant.
Surg Clin North Am.
2006;
86
937-967
41
Siproudhis L, Sebille V, Pigot F, Hemery P, Juguet F, Bellisant E.
Lack of efficacy of botulinum toxin in chronic anal fissure.
Aliment Pharmacol Ther.
2003;
18
515-524
42
Tranqui P, Trottier D C, Victor J C, Freeman J B.
Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin.
Can J Surg.
2006;
49
41-45
43
Trcinski R, Dziki A, Tchórzewski A.
Injections of botulinum A toxin for the treatment of anal fissures.
Eur J Surg.
2002;
168
720-723
44
Utzig M J, Kroesen A J, Buhr H J.
Concepts in pathogenesis and treatment of chronic anal fissure - a review of the literature.
Am J Gastroenterol.
2003;
98
968-974
45
Wollina U, Abdel-Naser M B.
Pharmacotherapy of pompholyx.
Expert Opin Pharmacother.
2004;
5
1517-1522
46
Wollina U, Konrad H.
Botulinum toxin A in anal fissures: a modified technique.
J Eur Acad Dermatol Venereol.
2002;
16
469-471
47
Wollina U, Konrad H.
Managing adverse effects associated with botulinum toxin type A.
Am J Clin Dermatol.
2005;
6
141-150
48
Wollina U, Konrad H, Petersen S.
Botulinum toxin in dermatology - beyond wrinkles and sweat.
J Cosmet Dermatol.
2005;
4
223-227
Prof. Dr. U. Wollina
Klinik für Dermatologie und Allergologie · Krankenhaus Dresden-Friedrichstadt · Städtisches Klinikum · Akademisches Lehrkrankenhaus der TU Dresden
Friedrichstraße 41
01067 Dresden
Phone: 03 51 / 4 80 16 85
Fax: 03 51 / 4 80 12 19
Email: wollina-uw@khdf.de